Infectious disease & microbiology intelligence
ID & Microbiology Intelligence Brief
9 May 2026 · Sourced from WHO, ECDC, CDC · Cross-checked against primary evidence
Lead story
🔴 Active outbreak
Andes hantavirus cluster — MV Hondius (Oceanwide Expeditions)
A multi-country cluster of Andes hantavirus cardiopulmonary syndrome (HCPS) linked to the Dutch-flagged expedition vessel
MV Hondius has triggered a coordinated international health response. ECDC was notified 2 May 2026 via the EU Early
Warning and Response System (EWRS). The ship departed Ushuaia, Argentina on 1 April 2026. As of 8 May, the vessel is en route
to Tenerife (port of Granilla), with expected arrival 10 May. Passengers from 23 countries are on board, including 9 EU/EEA nations.
Total cases
(as of 8 May)
(as of 8 May)
8–9
WHO: 8 · UKHSA: +1 suspected
Lab-confirmed
(PCR)
(PCR)
5–6
ECDC: 5 · Wikipedia: 6 (8 May)
Deaths
3
1 confirmed Andes by PCR
Countries
(passengers/crew)
(passengers/crew)
23
9 EU/EEA nations (ECDC)
✎ Correction 1 — Departure date
Source stated “~March 20, 2026.” Multiple verified sources confirm departure from Ushuaia was
1 April 2026 (WHO DON599; Wikipedia). The illness onset dates of 6–28 April are internally
consistent with a 1 April departure. Confidence: >95%.
✎ Correction 2 — Lab-confirmed case count
Source stated “2–3 lab-confirmed.” As of 8 May 2026, ECDC reports 5 confirmed (PCR), 2 probable,
1 suspected. The earlier figure reflects early WHO DON data from 4 May and is now significantly outdated.
Confidence: >95%.
Key facts — verified
Virus strain
Confirmed
Andes hantavirus (ANDV), confirmed 6 May 2026. ANDV is the sole hantavirus species with documented
person-to-person (H2H) transmission, occurring with sustained close or intimate contact — not casual aerosol
spread comparable to SARS-CoV-2. Reservoir: Oligoryzomys longicaudatus (colilargo/rice rat), endemic
to southern South America. A documented superspreader event in Argentina previously produced 34 infections
from a single index case.
Incubation period
Partially corrected
Source stated “1–8 weeks.” ECDC guidance and primary literature (Vial et al. 2006, Emerg Infect Dis)
give 7 days to 6 weeks (median ~18 days; full range 7–39 days). WHO Director-General Tedros used
“up to 6 weeks” at the 7 May briefing. The 8-week upper bound appears in some secondary sources but is not
reflected in ECDC quarantine guidance (6 weeks) or in the primary peer-reviewed literature.
Clinical implication: further cases remain possible for several weeks from last exposure.
Case fatality rate
Consistent with evidence
Source stated “up to ~50%.” Historical HCPS case fatality for Andes infection: approximately 35–50%.
This outbreak: 3 deaths from 8–9 cases ≈ 33–37% to date. The stated range is consistent with published data.
US CDC historical data (1993–2023, all hantavirus, n=890): 35% case fatality.
Primary exposure source
Unconfirmed — speculative
Source stated “rats on ship in Argentina” as the suspected index rodent exposure event. While rodent-to-human
transmission via aerosolised excreta (urine, faeces, saliva) is the established mechanism for Andes index cases,
the specific claim of shipboard rodent infestation has not been confirmed in any WHO, ECDC, or CDC
official communication reviewed. This remains under active investigation. Treat as working hypothesis, not
established fact.
Current hospitalisations and affected countries
Updated
As of 8 May: cases hospitalised in South Africa, Netherlands, Germany, Saint Helena, and Switzerland.
The country list in the source report (Chile, Spain/Catalonia, Italy, New Jersey) was incomplete and partially
unverifiable against current official sources.
United States: 17 passengers total; monitoring active across Arizona, California, Georgia, Virginia, and Texas. US government medical repatriation flight planned to Offutt Air Force Base, Nebraska. CDC team deployed to Canary Islands and Offutt AFB.
United Kingdom: 19 passengers + 4 crew; 7 disembarked at St Helena on 24 April; one passenger medically evacuated to South Africa. UKHSA monitoring active.
Switzerland: One confirmed case hospitalised at University Hospital Zurich; wife self-isolating.
United States: 17 passengers total; monitoring active across Arizona, California, Georgia, Virginia, and Texas. US government medical repatriation flight planned to Offutt Air Force Base, Nebraska. CDC team deployed to Canary Islands and Offutt AFB.
United Kingdom: 19 passengers + 4 crew; 7 disembarked at St Helena on 24 April; one passenger medically evacuated to South Africa. UKHSA monitoring active.
Switzerland: One confirmed case hospitalised at University Hospital Zurich; wife self-isolating.
Consensus risk assessment (WHO · ECDC · CDC): Risk to the general public is assessed as
very low. H2H transmission of Andes requires close, often prolonged or intimate contact;
pandemic potential is not supported. No passengers currently symptomatic (WHO briefing, 7 May).
Self-quarantine guidance: 6 weeks from last possible exposure, with weekly monitoring by public health services.
Other topics in brief
Antimicrobial Resistance
Rising resistance in Pacific island Gram-negatives; Lancet 39 million projection
Fiji study (JAC-AMR) highlights resistance burden in WHO-critical Gram-negatives in Pacific LMICs.
Separate Lancet modelling forecasts up to 39 million direct AMR-attributable deaths by 2050.
One Health framing prominent (Cyprus farming/AMR event). Innovation bottlenecks in the antibiotic pipeline
continue to attract discussion alongside phage therapy and AI diagnostics. TARGet AMR webinar: environmental
monitoring and genotype prediction.
Vaccines
mRNA influenza Phase 3; malaria mortality data; hantavirus vaccine context
NEJM/Fluent mRNA influenza Phase 3 trial in older adults generating non-inferiority and superiority debate on
antibody response endpoints. WHO and BMJ data on RTS,S/R21 malaria vaccine showing significant child mortality
reduction in Ghana, Kenya, and Malawi. Hantavirus vaccine trial references resurfacing in context of current
Andes cluster — no licensed hantavirus vaccine currently exists.
IPC / Emerging Signals
Multi-country H2H hantavirus IPC logistics; environmental AMR surveillance gaps
Multi-country evacuation and isolation logistics for rare H2H hantavirus exposing operational gaps in
travel medicine frameworks and port/airport surveillance. ASLM One Health diagnostics podcast on
self-medication and AMR in Africa. Environmental AMR spread and surveillance monitoring discussed at
TARGet AMR webinar.
Active uncertainties and ongoing debates
–
Exact index exposure event on MV Hondius — rodent source, timing, and location remain under investigation by WHO/ECDC.
–
Full extent of H2H transmission chain on the vessel; secondary transmission risk among household and sexual contacts of disembarked passengers.
–
mRNA influenza Phase 3 trial: clinical significance of non-inferiority threshold and antibody titre endpoint interpretation.
–
Minority speculation on hantavirus lab origin or exaggerated pandemic risk circulating on social media — not supported by official WHO, ECDC, or CDC assessments.
Primary sources
- WHO Disease Outbreak News DON599 (4 May 2026) and WHO Director-General media briefing (7 May 2026)
- ECDC Rapid Risk Assessment — Hantavirus-associated cluster on a cruise ship (6 May & 8 May 2026)
- CDC Media Statement and Update — MV Hondius hantavirus (7–8 May 2026)
- US State Department Statement — MV Hondius (updated 7 May 2026)
- Vial PA et al. Incubation period of hantavirus cardiopulmonary syndrome. Emerg Infect Dis. 2006;12(8):1271–3.
- Wikipedia — MV Hondius hantavirus outbreak (last updated 9 May 2026; used for case count triangulation only)